Tags Clean Tech
Tag: Clean Tech
BioLargo expands PFAS, Clyra, and BLEST operations while working to recover from the financial fallout tied to Pooph®.
BioLargo enters early commercialization with Clyra and PFAS, but steep revenue loss from Pooph® collapse leaves execution and scaling critical in 2026.
BioLargo's Q3 2025 report shows tech traction in PFAS, Clyra™, and Cellinity™ — but monetization remains elusive post-Pooph® fallout.
The Musk–Milei axis signals a potential U.S.–Argentina partnership, uniting lithium, liberty, and industrial leverage in a race for Latin American dominance.
BioLargo's Q2 exposes value-chain gaps—regulatory lags, partner dependency, and no clear path from validation to revenue.
BioLargo’s growth hinges on its AEC, Clyra™, and Pooph® innovations, but delays and cash burn turn Q2–Q3 into a critical test for its long-term ambitions.
BioLargo CEO Dennis P. Calvert appointed to the U.S. Environmental Technologies Trade Advisory Committee as company celebrates 80% revenue growth in 2024.
BioLargo, Inc. starts its Lake Stockholm PFAS removal pilot this month with its efficient AEC technology, reducing hazardous waste by over 99% compared to GAC.
